{"database": "lobbying", "table": "lobbying_activities", "rows": [[2865289, "c3994e5a-ca36-4017-8a4a-c5870053eb40", "Q3", "DESIMONE CONSULTING, LLC", 400931695, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2022, "third_quarter", "PHA", "Issues related to patient access and pricing; Issues related to policy changes to Medicare Part D; Issues related to PBM reform; PDUFA Reauthorization, H.R.7667, Food and Drug Amendments of 2022, S.4348, FDASLA Act of 2022; FY2022 Budget Reconciliation (H.R.5376); H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2022-10-14T12:52:26-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2865289"], "units": {}, "query_ms": 0.5144760943949223, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}